Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial
1 other identifier
interventional
21
0 countries
N/A
Brief Summary
Background: To profile gingival crevicular fluid (GCF) β-Catenin, 8-OHdG, and total antioxidants capacity (TAC) in periodontitis patients during healing of periodontal pockets following non-surgical periodontal therapy (NSPT).Methods: Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedStudy Start
First participant enrolled
July 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2026
May 19, 2026
May 1, 2026
4 months
May 7, 2026
May 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
periodontal pocket depth
periodontal pocket depth reduction
3 months
measurement of probing pocket depth (PPD)
measuring probing pocket depth (PPD)
3 months
measurement of clinical attachment loss (CAL)
clinical attachment loss (CAL)
3 months
Secondary Outcomes (1)
GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA) in which all have the same measuring units
3 months
Study Arms (1)
periodontitis patients with pocket depth
EXPERIMENTALInterventions
Periodontitis patients (n = 21) will included in this clinical trial. Clinical periodontal parameters will recorded and GCF samples will collected from randomly selected 4-6 mm periodontal pockets at baseline (T0) as well as 4 weeks (T1) and 12 weeks (T2) after NSPT. GCF levels of β-catenin, 8-OHdG, and TAC will be assayed by enzyme linked immunosorbent assay (ELISA).
Eligibility Criteria
You may qualify if:
- patients over 18 years old
- patients with periodontal pockets depth more than 4 mm
You may not qualify if:
- Pregnant women
- patients taking antibiotic within the last three months
- Patients with systemic disease ( Diabetes mellitus)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zeyad Nazarlead
- Babylon Universitycollaborator
Related Publications (1)
Vitkov L, Singh J, Schauer C, Minnich B, Krunic J, Oberthaler H, Gamsjaeger S, Herrmann M, Knopf J, Hannig M. Breaking the Gingival Barrier in Periodontitis. Int J Mol Sci. 2023 Feb 25;24(5):4544. doi: 10.3390/ijms24054544.
PMID: 36901974BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 7, 2026
First Posted
May 19, 2026
Study Start (Estimated)
July 15, 2026
Primary Completion (Estimated)
November 15, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 19, 2026
Record last verified: 2026-05